Cargando…

Nutrition, gut microbiota and immunity: Therapeutic targets for IBD

Detalles Bibliográficos
Autor principal:	Puri, A.S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2016
Materias:	Book Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5094131/ http://dx.doi.org/10.4103/0971-5916.192085

Ejemplares similares

Nutrition, IBD and Gut Microbiota: A Review
por: Mentella, Maria Chiara, et al.
Publicado: (2020)

Alteration of Gut Microbiota in Inflammatory Bowel Disease (IBD): Cause or Consequence? IBD Treatment Targeting the Gut Microbiome
por: Khan, Israr, et al.
Publicado: (2019)

Leaky Gut in IBD: Intestinal Barrier–Gut Microbiota Interaction
por: Yu, Shunying, et al.
Publicado: (2022)

Modulating Composition and Metabolic Activity of the Gut Microbiota in IBD Patients
por: Matijašić, Mario, et al.
Publicado: (2016)

The Gut Microbiota as a Therapeutic Target in IBD and Metabolic Disease: A Role for the Bile Acid Receptors FXR and TGR5
por: Baars, Annemarie, et al.
Publicado: (2015)

Overcoming challenges in IBD management
por: Ramakrishna, B.S.
Publicado: (2015)

The gut microbiota heterogeneity and assembly changes associated with the IBD
por: Sun, Yang, et al.
Publicado: (2019)

Gut Microbiota beyond Bacteria—Mycobiome, Virome, Archaeome, and Eukaryotic Parasites in IBD
por: Matijašić, Mario, et al.
Publicado: (2020)

New insights into the interplay between autophagy, gut microbiota and inflammatory responses in IBD
por: Larabi, Anaïs, et al.
Publicado: (2019)

Gut Serpinome: Emerging Evidence in IBD
por: Mkaouar, Héla, et al.
Publicado: (2021)

Nutritional Approach Targeting Gut Microbiota in NAFLD—To Date
por: Moszak, Małgorzata, et al.
Publicado: (2021)

Biotherapy Using Probiotics as Therapeutic Agents to Restore the Gut Microbiota to Relieve Gastrointestinal Tract Inflammation, IBD, IBS and Prevent Induction of Cancer
por: Dahiya, Divakar, et al.
Publicado: (2023)

Nutritional Interventions Targeting Gut Microbiota during Cancer Therapies
por: Rinninella, Emanuele, et al.
Publicado: (2021)

New therapeutic targets for cancer: the interplay between immune and metabolic checkpoints and gut microbiota
por: Agrawal, Babita
Publicado: (2019)

Fungal microbiota dysbiosis in IBD
por: Sokol, Harry, et al.
Publicado: (2017)

Nutritional interventions for the treatment of IBD: current evidence and controversies
por: Pigneur, Bénédicte, et al.
Publicado: (2019)

Nutritional Assessment in Inflammatory Bowel Disease (IBD)—Development of the Groningen IBD Nutritional Questionnaires (GINQ)
por: Peters, Vera, et al.
Publicado: (2019)

In Silico Evaluation of Putative S100B Interacting Proteins in Healthy and IBD Gut Microbiota
por: Orsini, Massimiliano, et al.
Publicado: (2020)

Editorial: IBD Management—Novel Targets and Therapeutic Perspectives
por: Antonioli, Luca, et al.
Publicado: (2020)

The oral-gut axis: a missing piece in the IBD puzzle
por: Kitamoto, Sho, et al.
Publicado: (2023)

Parkinson’s Disease and the Gut: Symptoms, Nutrition, and Microbiota
por: Yemula, Nehal, et al.
Publicado: (2021)

Nutrition, Gut Microbiota, and Allergy Development in Infants
por: Rey-Mariño, Alejandra, et al.
Publicado: (2022)

Effect of Non-Nutritive Sweeteners on the Gut Microbiota
por: Conz, Andrea, et al.
Publicado: (2023)

Intercontinental Gut Microbiome Variances in IBD
por: Mayorga, Luis, et al.
Publicado: (2022)

Role and Effective Therapeutic Target of Gut Microbiota in Heart Failure
por: Jia, Qiujin, et al.
Publicado: (2019)

Diet and Nutrition in IBD—Progress and Gaps
por: Raman, Maitreyi, et al.
Publicado: (2019)

Gut Microbiota as Potential Therapeutic Target for the Treatment of Cow’s Milk Allergy
por: Canani, Roberto Berni, et al.
Publicado: (2013)

Next-Generation Therapeutics for IBD
por: Löwenberg, Mark, et al.
Publicado: (2015)

Could the Gut Microbiota Serve as a Therapeutic Target in Ischemic Stroke?
por: Zhang, Jiyao, et al.
Publicado: (2021)

The gut microbiota in neurodegenerative diseases: revisiting possible therapeutic targets for cannabidiol
por: Oliveira, Bruna Stefane Alves de, et al.
Publicado: (2022)

Gut Microbiota, in the Halfway between Nutrition and Lung Function
por: Espírito Santo, Christophe, et al.
Publicado: (2021)

Intestinal Immune Imbalance is an Alarm in the Development of IBD
por: Hu, Chunli, et al.
Publicado: (2023)

Gut Microbiota as a Target for Preventive and Therapeutic Intervention against Food Allergy
por: Aitoro, Rosita, et al.
Publicado: (2017)

Gut Microbiota Composition and Cardiovascular Disease: A Potential New Therapeutic Target?
por: Belli, Martina, et al.
Publicado: (2023)

Dendritic cells in IBD pathogenesis: an area of therapeutic opportunity?
por: Bates, Jennifer, et al.
Publicado: (2014)

Organoid-based Models to Study the Role of Host-microbiota Interactions in IBD
por: Poletti, Martina, et al.
Publicado: (2020)

Metabolic Host–Microbiota Interactions in Autophagy and the Pathogenesis of Inflammatory Bowel Disease (IBD)
por: Dowdell, Alexander S., et al.
Publicado: (2021)

Therapeutic Drug Monitoring of Biologics in IBD: Essentials for the Surgical Patient
por: Nones, Rodrigo Bremer, et al.
Publicado: (2021)

Deviations in human gut microbiota: a novel diagnostic test for determining dysbiosis in patients with IBS or IBD
por: Casén, C., et al.
Publicado: (2015)

Oral versus intravenous iron replacement therapy distinctly alters the gut microbiota and metabolome in patients with IBD
por: Lee, Thomas, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_au038efsbillf7pvlvclv8umvv